Clinically significant chronic liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

by Morling, Joanne R., Fallowfield, Jonathan A., Guha, Indra N., Williamson, Rachel M., Glancy, Stephen, Strachan, Mark W.J., Price, Jackie F.
Published 2016

γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes S...

by Morling, Joanne R., Fallowfield, Jonathan A., Williamson, Rachel M., Robertson, Christine M., Glancy, Stephen, Guha, Indra N., Strachan, Mark W. J., Price, Jackie F.
Published 2015

Osteopontin Is a Novel Downstream Target of SOX9 With Diagnostic Implications for Progression of Liver Fibrosis in Humans

by Pritchett, James, Harvey, Emma, Athwal, Varinder, Berry, Andrew, Rowe, Cliff, Oakley, Fiona, Moles, Anna, Mann, Derek A, Bobola, Nicoletta, Sharrocks, Andrew D, Thomson, Brian J, Zaitoun, Abed M, Irving, William L, Guha, Indra N, Hanley, Neil A, Hanley, Karen Piper
Published 2012

SOX9 predicts progression towards cirrhosis in patients while its loss protects against liver fibrosis

by Athwal, Varinder S., Pritchett, James, Llewellyn, Jessica, Martin, Katherine, Camacho, Elizabeth, Raza, Sayyid M.A., Phythian-Adams, Alexander, Birchall, Lindsay J., Mullan, Aoibheann F., Su, Kim, Pearmain, Laurence, Dolman, Grace, Zaitoun, Abed M., Friedman, Scott L., MacDonald, Andrew, Irving, William L., Guha, Indra N., Hanley, Neil A., Hanley, Karen Piper
Published 2017